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ABSTRACT  1 
Chronic wounds cause significant patient morbidity and mortality. A key factor in their 2 
etiology is microbial infection, yet skin host-microbiota interactions during wound repair 3 
remain poorly understood. We investigated microbiome profiles of non-infected human 4 
chronic wounds and showed that reduced diversity was associated with subsequent healing 5 
outcome. Furthermore, poor clinical healing outcome was associated with increased local 6 
expression of the pattern recognition receptor NOD2. To investigate NOD2 function in the 7 
context of cutaneous healing, we treated mice with the NOD2 ligand muramyl dipeptide 8 
(MDP) and analyzed wound repair parameters and expression of anti-microbial peptides. 9 
MDP treatment of littermate controls significantly delayed wound repair associated with 10 
reduced re-epithelialization, heightened inflammation and upregulation of murine β-11 
Defensins (mBD) 1, 3 and particularly 14. We postulated that although BD14 might impact 12 
on local skin microbial communities it may further impact other healing parameters. Indeed, 13 
exogenously administered mBD14 directly delayed mouse primary keratinocyte scratch 14 
wound closure in vitro. To further explore the role of mBD14 in wound repair, we employed 15 
Defb14-/- mice, and showed they had a global delay in healing in vivo, associated with 16 
alterations in wound microbiota. Taken together these studies suggest a key role for NOD2-17 
mediated regulation of local skin microbiota which in turn impacts on chronic wound 18 
etiology.   19 
  20 
 21 
 22 
23 
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INTRODUCTION 1 
Chronic wounds, which include pressure sores, venous and diabetic foot ulcers (DFUs), are a 2 
global problem leading to substantial morbidity and mortality (Gottrup, 2004).  Following 3 
injury, skin-resident microbiota and pathogenic species may colonise the wound and 4 
proliferate (Eming et al., 2014). Hence understanding the role of bacteria, both pathogenic 5 
and commensal, in the context of skin wounding is important yet comparatively little research 6 
attention has focused on this area (Loesche et al., 2017, Misic et al., 2014).  7 
 8 
Poor progression of chronic wounds is often associated with infection and the presence of 9 
recalcitrant microbial biofilms comprising Staphylococcus, Pseudomonas and 10 
Corynebacterium and a variety of other organisms (Attinger and Wolcott, 2012, James et al., 11 
2008, Mancl et al., 2013, Rhoads et al., 2012). The innate immune system detects infection 12 
and injury via pattern recognition receptors (PRRs), such as the Nod-like receptors. PRRs 13 
respond to highly conserved microbial structures- pathogen-associated molecular patterns 14 
that can trigger inflammatory and defense responses such as keratinocyte-mediated 15 
production of anti-microbial peptides (AMPs). AMPs provide rapid and efficient anti-16 
microbial activity against a wide range of pathogens (Dutta and Das, 2016, Harder et al., 17 
2013). The skin has many AMPs including Cathelicidins, β-defensins, S100A15, RNase-7 18 
and Histones (Buchau et al., 2007, Dorschner et al., 2001, Gallo and Hooper, 2012, 19 
Halverson et al., 2015, Simanski et al., 2010, Sorensen et al., 2006, Yang et al., 2017) and 20 
induces members of the β-defensin family under conditions of inflammation, infection and 21 
wound healing (Mangoni et al., 2016, Schneider et al., 2005) .  22 
 23 
Several pivotal studies have provided insight into the host response during cutaneous wound 24 
repair (Campbell et al., 2013, Grice et al., 2010) yet relatively little is known about the skin 25 
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microbiota and whether they have detrimental or beneficial impacts on repair. Here, we 1 
demonstrate an association between the bacterial profile of non-infected human DFUs and 2 
healing outcome, correlating with upregulated expression of the PRR NOD2. Using both 3 
NOD2 stimulated and Defb14 null murine models we reveal new insights into the role of the 4 
innate defense response in controlling the skin microbiota during wound repair. 5 
 6 
RESULTS 7 
Human chronic wound microbiome is linked to healing outcome 8 
Patients were recruited with chronic non-infected DFUs (Grade A1/B1, no infection or 9 
ischemia at the time of presentation). Total eubacterial diversity was profiled using 16S PCR-10 
Density Gradient Gel Electrophoresis (16S PCR-DGGE) on DFU punch biopsy tissue 11 
collected at clinical presentation (week 0). Patients were then separated into two groups 12 
according to their time to heal over a period of 12 weeks; DFU healed ≤7 weeks (n = 10) 13 
versus non-healed ≥12 weeks (n = 9). Eubacterial DNA profiles (UPGMA dendrogram) at 14 
presentation (week 0) showed clear segregation between wounds that would heal versus those 15 
that would not (Figure 1a; wound closure at ≤7 weeks (green) versus ≥12 weeks (purple), n = 16 
19). 16S rRNA Illumina high-throughput sequencing of a further set of DFU samples (n = 17 
25) and non-metric multi-dimensional analysis (NMDS) showed no clear separation between 18 
the microbial profiles of the healed compared to the non-healed wounds (Figure 1b); 19 
however, non-healing wounds were associated with significantly reduced overall phylum 20 
diversity (Figure 1c). Phylum level relative abundance was consistent between healed and 21 
non-healed wounds (Fig 1d); however, interestingly genus level taxonomic classification of 22 
the wound microbiome revealed a significantly altered microbial community in healed versus 23 
non-healed wounds, including relative abundance variation within common skin-associated 24 
taxa such as Staphylococcus (23% in healed wounds versus 19% in non-healing wounds), 25 
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Anaerococcus (3% in healed wounds versus 10% in non-healing wounds) and Coprococcus 1 
(classified in other genera category, Figure 1e (P=<0.05)). The taxonomic information for all 2 
mapped reads at the genus level can be found in the supplementary material (Table S2). 3 
Finally, the overall presence of bacteria in wounds was assessed by direct Gram stain of DFU 4 
biopsy tissue which revealed no significant difference in bacterial numbers between the 5 
groups (Figure 1f-g). Collectively this data suggests that bacterial community diversity rather 6 
than overall bacterial burden correlates with DFU healing outcome.  7 
 8 
NOD2 is upregulated in human chronic wounds that fail to heal 9 
We next assessed whether PRR expression was altered as PRRs have been implicated in the 10 
skin microbiome regulation (Campbelle t al., 2013, Dasu et al., 2010, Lai et al., 2009, Lin et 11 
al., 2012). Several TLRs trended towards increased expression in non-healing wounds 12 
(Figure 2a-e) but only the intracellular PRR NOD2 was significantly increased (P<0.05, 13 
Figure 2f). NOD2 is implicated in barrier function, epithelial turnover and repair 14 
(Cruickshank et al., 2008) therefore we investigated NOD2 function in keratinocytes. 15 
Keratinocyte scratch wound closure was significantly reduced following treatment with the 16 
NOD2 ligand, MDP (P<0.05, Figure 2g-h). Scratch closure was also inhibited by a range of 17 
TLR ligands (Figure S1a); however, TLR2 ligands did not affect closure. The addition of 18 
mitomycin C to inhibit proliferation (Figure 2h) showed no difference in migration between 19 
MDP treatment and control, implicating NOD2 signalling in the proliferative component of 20 
scratch wound closure. qPCR confirmed that MDP treatment significantly increased 21 
keratinocyte mRNA expression of NOD2 (P<0.05, Figure 2i). 22 
 23 
Experimental stimulation of the NOD2 pathway delays cutaneous wound healing 24 
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We next investigated the impact of NOD2 activation using C57BL/6 mice subcutaneously 1 
injected with MDP or vehicle control, prior to incisional wounding. MDP treatment 2 
upregulated Nod2 mRNA in the wound (Figure S1b) and showed a trend for upregulation of 3 
the Nod2 associated downstream signalling molecules Rip2 but not Tak1, (Figure S1c-d). 4 
MDP treatment significantly delayed wound closure (Figure 3a) demonstrated by increased 5 
histological wound area (P<0.001, Figure 3b) and reduced re-epithelialization (P<0.01, 6 
Figure 3c). MDP-treated wounds had increased local wound recruitment of both neutrophils 7 
(P<0.001) and macrophages (P<0.01, Figure 3d-f) and we observed an extended keratinocyte 8 
activation response (extension of keratin 6 staining from the wound edge compared to 9 
control; P<0.01, Figure 3g-h). In line with these results, Ki67 staining in MDP treated 10 
wounds, demonstrated significantly increased wound edge proliferation in MDP-treated 11 
wounds (Figure 3i-j). Collectively, these results demonstrate that MDP-mediated activation 12 
of NOD2 significantly delays repair.  13 
 14 
NOD2 stimulation induces an anti-microbial response in cutaneous wound healing  15 
NOD2 has a known role in gut and lung epithelial AMP production specifically defensins 16 
(Rohrl et al., 2008, Tan et al., 2015). MDP treated wounds had significantly upregulated 17 
levels of mBD3 (P<0.05) and mBD14 (P<0.05) mRNA compared to control wounds (Figure 18 
4a). Similarly, in vitro, MDP stimulated NHEKs significantly induced hBD1, hBD2 (the 19 
human orthologue to mBD3) and particularly hBD3 (the human orthologue to mBD14; 20 
P<0.05, Figure 4b). We further explored the effect of mBD14 on wound healing, focusing on 21 
the keratinocyte response. We used a mBD14 peptide (Reynolds et al., 2010), which we 22 
confirmed as biologically active as it inhibited P. aeruginosa growth  (Figure S2a) and 23 
scratch-wounded primary mouse keratinocyte monolayers were treated with 1, 10 or 25 24 
µg/ml of mBD14 peptide. Keratinocyte migration was significantly decreased in a dose-25 
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dependent manner (P<0.01, Figure 4c-d). Importantly, cell viability was unaffected by the 1 
peptide as determined by examination of morphological features, suggesting that mBD14 2 
directly influences epidermal migration. The sequence homology between mBD14 and hBD3 3 
is approximately 69% (Hinrichsen et al., 2008, Rohrlet al., 2008), therefore we tested mBD14 4 
peptide on human keratinocytes with similar results (Figure S2b).  We also investigated the 5 
impact of hBD3 on keratinocyte function using hBD3 transfected cells; however, we saw no 6 
effect on keratinocyte scratch closure (Figure S2c).  7 
 8 
β-defensin 14 null mice had delayed wound healing 9 
To further clarify the role of mBD14 we investigated excisional wound healing in mice that 10 
lack BD14 (Defb14-/-) and WT littermate controls. Histological analysis revealed delayed in 11 
wound repair in Defb14-/- mice (Figure 5a), with significantly increased wound area (P<0.01, 12 
Figure 5b) and delayed re-epithelialization (P<0.05, Figure 5c) at 3 days post-wounding. 13 
There was a significant reduction in neo-epidermal area although no difference in the 14 
distance contribution of keratin 6 expressing cells (P<0.05, Figure 5d-f).  Defb14-/- wounds 15 
had an extended epidermal proliferative response compared to control, with increased 16 
numbers of Ki67 expressing basal keratinocytes at the peri-wound edge (P<0.05, Figure 5g-17 
h). Examination of the immune cells revealed no change in wound neutrophils (Figure 5i), 18 
but significantly increased macrophages suggesting altered immune response dynamics 19 
(P<0.01; Figure 5j). Defb14-/- wounds had increased wound granulation tissue iNOS+ cells 20 
(associated with classically activated macrophages) at 3 days post-wounding (P<0.01, Figure 21 
5k), and a concomitant trend towards a decrease in Arg1+ cells  (expressed by alternatively 22 
activated macrophages) compared to controls (Figure 5l). Collectively, these data suggest an 23 
altered epidermal response and a highly pro-inflammatory local wound environment in the 24 
absence of  β-defensin 14.  25 
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 1 
β-defensin 14 null mice have an altered wound bacterial profile  2 
Chronic wounds had altered communities of bacteria compared with wounds that healed well 3 
and we had shown that mBD14 peptide inhibited the growth of P. aeruginosa (Figure S2a) 4 
therefore, we assessed bacterial abundance in Defb14-/- mice. Total eubacterial abundance 5 
was significantly increased in Defb14-/- mice compared to controls as revealed by Gram-6 
staining (P<0.01, Figure 6a-b) and 16S qPCR (P<0.05, Figure 6c). qPCR analysis of 7 
common skin bacterial species revealed increased levels of P. aeruginosa (P<0.01) as well as 8 
P. acnes (P<0.05, Figure 6d-g) implicating BD14 in a bacterial dysbiosis that is detrimental 9 
to healing.  10 
 11 
DISCUSSION  12 
Human skin is colonized by a diverse array of bacteria and microbes that generally live in 13 
harmony with the host, yet overgrowth of commensal species or pathogen infection can 14 
negatively impact healing (Grice and Segre, 2012a, 2012b). While the precise relationship 15 
between the microbes and healing remains unclear, diabetic wounds are thought to be 16 
colonized by distinct microbiota compared to normally healing wounds including increased 17 
Pseudomonas aeruginosa (Grice et al., 2010, Hinojosa et al., 2016, Price et al., 2011). 18 
However, not all wounds fail to heal and it remains unclear whether an altered skin 19 
microbiota is associated with a predisposition to delayed healing. The data presented here 20 
suggest that in the absence of clinical infection, microbiome profiles (and associated host 21 
response) play an important role in determining subsequent healing outcome. Thus, bacteria 22 
present on our skin prior to injury could dictate how we heal.   23 
 24 
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In DFU patients, rather than the more "common" wound pathogens, we observed changes in 1 
genera abundance such as Corynebacterium, Enterococcaceae, and Helcococcus associated 2 
with non-healing. We assessed the DFU microbiome at time of clinical presentation before 3 
the outcome of healing was known. Previous and complimentary longitudinal analysis of 4 
DFU-associated bacteria have linked poor healing to a more stable microbiome, whereas 5 
wounds that healed well had a more dynamic microbiome that transitioned between 6 
community types (Loesche et al., 2017). Similarly, our findings implicate a less diverse 7 
microbiome at the initiation of healing, which may in turn impact upon the subsequent 8 
dynamics of the microbiome during healing. It remains unclear whether such observations 9 
will be broadly applicable to other wound types such as venous leg ulcers, decubitus ulcers 10 
and wounds that fail to heal by secondary intention. Studies do, however, suggest that neither 11 
patient demographics nor wound type exert major influence on the bacterial composition of 12 
the chronic wound microbiome (Wolcott et al., 2016).  13 
 14 
Several previous studies have shown that TLRs are differentially regulated when comparing 15 
acute wounds to chronic wounds, while a number of PRRs, such as TLR3, are important for 16 
wound chronicity (Campbell et al., 2013, Dasu et al., 2010, Lai et al., 2009, Lin et al., 2012). 17 
By contrast, our study tested PRR levels in longitudinally evaluated healing versus non-18 
healing chronic wounds. In this context, the only PRR to show statistically significant 19 
alteration was NOD2. As the expression of NOD2 can be upregulated in response to bacterial 20 
ligation, it is plausible that the observed differential NOD2 levels in non-healing wounds may 21 
reflect a response to the differential bacterial composition of the wound environment.  22 
 23 
We further investigated the effect of experimentally activating NOD2 in a murine model, via 24 
the ligand muramyl dipeptide (MDP). Here MDP treatment led to a significant delay in 25 
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healing. Studies have linked NOD2 dysregulation to an altered innate immune response, 1 
susceptibility to inflammation and delayed healing in acute wounds from elderly subjects 2 
(Hardman and Ashcroft, 2008, Lesage et al., 2002). NOD2, but not TLR2, has an essential 3 
role during re-epithelialisation following murine cutaneous injury (Campbell et al., 2013), 4 
and in the murine gut NOD2 regulates epithelial turnover and immune cell recruitment 5 
(Bowcutt et al., 2014, Cruickshank et al., 2008).  In the clinical setting, mutations in NOD2 6 
are linked to the rare inflammatory skin condition Blau syndrome and delayed wound healing 7 
(Kurokawa et al., 2003). Functional studies, have shown that both loss-of-function and gain-8 
of-function mutations in NOD2 are associated with chronic inflammation (Kobayashi et al., 9 
2005, Watanabe et al., 2004). This apparent dichotomy is thought to be because NOD2 can 10 
directly drive pro-inflammatory signals as well as inhibit other pathways such as the TLR2 11 
mediated pathway of inflammation (Watanabe et al., 2004). Other research suggests that the 12 
ability of NOD2 to mediate a pro-inflammatory or anti-inflammatory effect is dependent 13 
upon the nature of accessory factors present, such as cytokines or bacterial products (Feerick 14 
and McKernan, 2017). In this context, both NOD2 overexpression in human chronic wounds 15 
and Nod2 stimulation in murine wounds is associated with delayed wound closure.  16 
 17 
NOD2 has a well-characterized role in the recognition and clearance of intracellular bacteria 18 
through activation of the pro-inflammatory pathway and other host defense pathways 19 
including AMPs (Philpott et al., 2014). In addition to anti-microbial roles (Hinrichsen et al., 20 
2008), AMPs have been shown to modulate cytokine production (e.g. IL-1β, IL-22), 21 
keratinocyte migration and proliferation, and angiogenesis (Harder et al., 2013, Ong et al., 22 
2002). MDP stimulation of NOD2 led to a significant upregulation of mBD3 and 14 (mouse 23 
orthologue of human hBD2 and 3) in keratinocytes in vitro and wounded skin in vivo. 24 
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Dysregulation of AMPs in the skin may be an important factor in the host susceptibility to 1 
bacterial colonization and wound repair.  2 
 3 
Specific loss of Defb14 (mDB14) severely impaired multiple aspects of wound healing, with 4 
reduced re-epithelization, increased inflammation and a higher bacterial burden including P. 5 
aeruginosa, which we have previously shown to be detrimental to the healing response 6 
(Williams et al., 2017). These findings support previous observations that AMPs have diverse 7 
functions, including modulation of the innate immune system and altering TLR 8 
responsiveness (Beaumont et al., 2014, McGlasson et al., 2017, Semple et al., 2015, Wang et 9 
al., 2017). Some AMPS, such as cathelicidin, promote neutrophil recruitment and anti-10 
microbial-activity and indeed Defb14-/- mouse wounds displayed limited neutrophil 11 
recruitment, despite delayed healing and a higher bacterial burden (Beaumont et al., 2014, 12 
Choi et al., 2012, Mookherjee and Hancock, 2007). The role of BD14 in keratinocytes is 13 
particularly poorly understood. Here we showed that treatment of in vitro keratinocyte 14 
scratch assays with mBD14 impaired scratch closure, although it remains unclear whether 15 
this is a direct effect or the result of activating other keratinocyte pro-repair pathways, such as 16 
local cytokine production (Wang et al., 2017). 17 
 18 
Collectively our work suggests that a greater knowledge of host microbial interactions is 19 
essential to understand wound healing progression. Bacterial ligands and anti-microbial 20 
factors are almost invariably multifactorial in function, conveying both beneficial and 21 
detrimental impacts on healing. Specifically, understanding the dynamics of host-microbial 22 
interactions will be key for better managing the treatment of patients with chronic wounds. In 23 
the future simple diagnostic tests to rapidly stratify healing potential based on wound 24 
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bacterial composition will likely be coupled with bacteria-selective treatments and/or 1 
selective manipulation of the microbiome to promote healing. 2 
 3 
MATERIALS & METHODS 4 
Human chronic wounds 5 
Local ethical committee approval was obtained for all human studies, with informed consent 6 
obtained in accordance with the Declaration of Helsinki. 25 wound biopsy patient samples 7 
(mixed sex, aged ≥40 years) with chronic DFUs (defined as distal to the medial and lateral 8 
malleoli, with a known duration ≥4 weeks, grade A1/B1, University of Texas ulcer 9 
classification, no infection or ischaemia) were obtained at the time of presentation (week 0). 10 
All patients received standard-of-care treatment, including regular debridement, non-11 
antimicrobial dressing, and offloading. No local anaesthetic was used at any time during 12 
treatment. At week 0 wound biopsy samples were collected from the margin of DFUs prior to 13 
debridement using aseptic technique. Photographs of patient’s wounds were taken weekly 14 
over 12 weeks to determine longitudinal healing outcome. DFUs were then separated into 15 
two groups, those who healed (full wound closure at ≤7 weeks; 10 patients) and those who 16 
failed to heal (wound not closed at 12 weeks; 9 patients) following current best practice 17 
treatment.   18 
 19 
Generation of hBD3 expressing HaCaT cell line 20 
A human Beta Defensin 3 stably over-expressing HaCaT cell line was constructed by 21 
transfecting cells with a plasmid containing hBD3 cloned into pcDNA3.1 (kind gift of Julia 22 
Dorin, University of Edinburgh). Lipofectamine 2000 (Life Technologies) was used for 23 
transfection as per manufacturer’s guidelines. Stably transfected cells were selected for by 24 
addition of 500µg/ml G418 (Life Technologies). Overexpression of hBD3 in the stable cell 25 
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line compared to control vector transfected line was confirmed by Real Time PCR, using 1 
TaqMan primer probe to the coding region of hBD3 (Applied Biosystems, assay 2 
ID Hs04194486_g1).   3 
 4 
Cell culture and scratch migration assay 5 
HaCaT cells (established human keratinocyte cell line) were cultured in DMEM plus 5% 6 
FBS. Normal human epidermal keratinocytes (NHEK) (PromoCell, Heidelberg, UK,) were 7 
cultured in Keratinocyte Growth Medium 2 (PromoCell, C-20011) plus supplements 8 
(PromoCell). Primary murine keratinocytes were isolated and cultured (Hager et al., 1999), 9 
with collagen IV-coated plates and CnT-PR medium (CELLnTEC, Bern, Switzerland). 10 
Confluent keratinocyte sheets seeded in 24-well plates were ‘scratch wounded’ and treated 11 
with 1 µg/ml MDP (Bachem, St Helens, UK) with or without 20 µg/µl mitomycin C (Sigma-12 
Aldrich, Dorset, UK);  0-25 µg/ml mBD14; 1µg/ml Lipopolysaccharide (LPS); 1µg/ml 13 
Pam3-Cys; 107 CFU Staphylococcus aureus (SA); or 1µg/ml Peptidoglycan (PGN), for 24, 48 14 
or 96 hours. Images were captured on a Nikon Eclipse E600 microscope (Nikon, Surrey, UK) 15 
and a SPOT insight camera (Image solutions Inc, Lancashire, UK). Scratch closure was 16 
quantified using Image Pro Plus software (Media Cybernetics, Cambridge, UK) averaged 17 
from fifteen measurements per sample. Calculations for percent closure were based on 18 
epithelial scratch width after specified duration (D), in relation to width at time zero (T0) 19 
using the equation ((T0-D)/T0)100).   20 
 21 
RNA isolation and reverse transcription-quantitative PCR (RT-qPCR) 22 
Total host RNA was isolated using the Purelink RNA kit (Invitrogen™ by Life Technologies 23 
Ltd, Paisley, UK). cDNA was transcribed from 1 µg of RNA (Promega RT Kit, Hampshire, 24 
UK and AMVreverse transcriptase, Roche, West Sussex, UK) and qPCR performed using the 25 
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SYBR® Green 1 Kit (Eurogentec, Hampshire, UK) and an iCycler iQ quantitative PCR 1 
thermal cycler (Bio-Rad, Hertfordshire, UK). The primer sequences for real-time qPCR are 2 
listed in Table S1. 3 
 4 
DNA extraction from tissue samples and manipulation 5 
All tissue samples were incubated in enzymatic lysis buffer (20 mM Tris at pH 8.0, 0.2 mM 6 
EDTA, 1.2% triton X-100) and lysozyme (20 mg/ml) for 30 min at 37°C. DNA was extracted 7 
using a Qiagen DNeasy™ blood and tissue kit (Qiagen, West Sussex, UK).  8 
 9 
PCR amplification, purification and denaturing gradient gel electrophoresis (DGGE) 10 
The V3 variable region of the 16S rRNA gene was amplified from purified DNA by PCR 11 
using GC-rich eubacterium-specific primers P3_GC-341F and 518R (see Table S1) (Walter 12 
et al., 2000) using a PTC-100 DNA Engine thermal cycler (Bio-Rad). Samples were purified 13 
using a Qiagen MinElute® purification kit (Qiagen). Polyacrylamide electrophoresis was 14 
performed using the D-CODE Universal Mutation Detection System (Bio-Rad). Denaturing 15 
gradient gels of 10% (wt/vol) acrylamide-bisacrylamide (37:1:5) were made as described 16 
previously (Walter et al., 2000). DGGE gel images were aligned and analyzed with 17 
BioNumerics software version 4.6 (Applied Maths, Sint-Martens-Latem, Belgium) and 18 
profiles used to produce an Unweighted Pair Group Method with Arithmetic Mean 19 
(UPGMA) dendrogram.  20 
 21 
16S rRNA gene sequencing analysis 22 
16S amplicon sequencing targeting the V3 and V4 variable region of the 16S rRNA gene 23 
(Table S1) was performed on the Illumina MiSeq platform. The raw amplicon data was 24 
processed using quantitative insights into microbial ecology (QIIME) version 1.9.0 (Caporaso 25 
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et al., 2010), and R version 3.3.1 (Team, 2016). The NMDS plot was created using the 1 
isoMDS function in the ‘MASS’ package (Venables and Ripley, 2002) in R and statistical 2 
analysis performed using the ‘adonis’  function in the ‘vegan’ package in R. The Shannon 3 
Wiener Diversity Index was also calculated in R, using the ‘diversity’ function in the ‘vegan’ 4 
package (Okansen et al., 2016).  5 
 6 
Hucker-Twort Gram Stain 7 
The Hucker-Twort Gram stain was used to distinguish Gram-positive and Gram-negative 8 
bacteria in formalin-fixed tissue. Slides were imaged using a 3D-Histech Pannoramic-250 9 
Flash Slide Scanner (3D Histech, Budapest, Hungary), using a 20x/0.25 Plan Apochromat 10 
objective (Zeiss, Oberkochen, Germany).  All tissue was blinded before analysis. The sum of 11 
scores for relative amounts of Gram-positive and Gram-negative bacteria in the wound bed 12 
tissue was quantified based on CMPT (Clinical Microbiology Proficiency-Testing) guidelines 13 
(score 0 to 4+), zero (score 0), rare or scant (score 1+), few (score 2+), moderate (score 3+) 14 
and many, numerous or heavy (score 4+) with regard to the numbers of organisms present per 15 
oil immersion field (x100).  16 
 17 
Animals and wounding 18 
Following local ethics committee approval, all animal studies were conducted in accordance 19 
with UK Home Office regulations. Mice were housed in isolator cages with ad libitum food 20 
and water. Wild-type (WT) (C57BL/6J) mice were bred from WTxWT matings and Defb14 21 
null mice (C57BL/6J background) were bred from heterozygous matings and have been 22 
described previously (Navid et al., 2012). Eight week-old female WT mice were 23 
anaesthetized and injected subcutaneously with 10 µg MDP (MurNAc-L-Ala-D-isoGin) 24 
(Bachem, UK, G-1055) or vehicle (PBS), 24 hours and repeated 2 hours prior to wounding (n 25 
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= 10 mice/group). Mice were anaesthetized and wounded following our established protocol 1 
(Ansell et al., 2014). Briefly, two equidistant 1 cm full-thickness incisional or 6 mm 2 
excisional wounds were made through both skin and panniculus carnosus muscle at the 3 
injection site and left to heal by secondary intention.  4 
 5 
Histology and immunohistochemistry (IHC) 6 
Histological sections were prepared from tissue fixed in 10% buffered formalin saline and 7 
embedded in paraffin. 5 µM sections were stained with haematoxylin and eosin or subjected 8 
to IHC analysis using keratin 6, keratin 14 (Covance, Maidenhead, UK, PRB-169P and PRB-9 
155P); anti-Ki67 (Abcam, Cambridge, UK, ab16667); anti-neutrophil (Thermo Scientific, 10 
Runcorn, UK, MA1-40038); anti-Mac-3 (BD Biosciences, Oxford, UK, 553322); NOS2 11 
(Santa Cruz Biotechnology, Heidelberg, Germany, SC-651); and arginase-I (Santa Cruz 12 
Biotechnology, SC-18354). Primary antibodies were detected using the appropriate 13 
biotinylated secondary antibody followed by ABC-peroxidase reagent (Vector Laboratories, 14 
Peterborough, UK, PK-6104 or PK-6101) with NovaRed substrate (Vector Laboratories, SK-15 
4800) and counterstained with haematoxylin. Images were captured using a Nikon Eclipse 16 
E600 microscope (Nikon) and a SPOT insight camera (Image solutions Inc). Total immune 17 
cell numbers (quantification is illustrated in figure S3), granulation tissue wound area and 18 
percentage re-epithelialization were quantified using Image Pro Plus software (Media 19 
Cybernetics).  20 
 21 
Minimum Inhibitory Concentrations (MIC)  22 
MICs were determined using the microdilution method (Moore et al., 2008). Briefly, an 23 
overnight culture of Pseudomonas aeruginosa (NCTC 10781) was diluted in sterile Mueller-24 
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Hinton broth (Oxoid, Basingstoke, UK) to an OD600 of 0.5. The biologically active form of 1 
the mBD14 peptide (Reynolds et al., 2010),  2 
FLPKTLRKFFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRKKK (oxidized cysteines 3 
to form 3 disulfides) (Cambridge Peptides, Cambridge, UK), was serially diluted in 4 
inoculated media and incubated at 37°C for 24 hours with agitation. Growth was measured as 5 
light absorbance (495 nm) relative to un-inoculated and detected using a microtiter plate 6 
reader (Powerwave XS, Bio Tek Instruments, Potton, UK).  7 
 8 
Statistical analysis 9 
Normal distribution and statistical comparisons between groups were determined using 10 
Shapiro-Wilk test, Student’s t-test (two tailed), one or two-way ANOVA with Tukey post hoc 11 
test where appropriate using GraphPad Prism 7 Version 7.01 (GraphPad Software, Inc. La 12 
Jolla, CA) with the exception of the analysis for 16S rRNA gene sequencing analysis. For all 13 
statistical tests, the variance between each group was determined and probability values of 14 
less than P<0.05 were considered statistically significant.  15 
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CONFLICT OF INTEREST 17 
The authors state no conflict of interest. 18 
 19 
ACKNOWLEDGEMENTS 20 
The authors would like to thank Professor Andrew Boulton for providing chronic wound 21 
tissue, Professor Werner Muller for generous provision of Defb14 null mice, and Dr 22 
Catherine Walker and Dr Sarah Forbes for valuable technical assistance with design of BD14 23 
peptide. The Histology Facility equipment that was used in this study was purchased by the 24 
University of Manchester Strategic fund. Special thanks go to Peter Walker for his help with 25 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
18 
 
the histology. The Bioimaging Facility microscopes used in this study were purchased with 1 
grants from BBSRC, Wellcome and the University of Manchester Strategic Fund. Special 2 
thanks go to Roger Meadows for help with microscopy and image analysis. This research was 3 
supported by an AgeUK Senior Fellowship (M.J.H), MRC Centenary award (M.J.H and 4 
A.J.M)  and the Medical Research Council (MRC) project grant G1000449 (M.J.H and S.C.). 5 
DD was funded by an MRC senior non-clinical fellowship (G1002046). 6 
 7 
REFERENCES 8 
Ansell D. M., Campbell L., Thomason H. A., Brass A., Hardman M. J. A statistical analysis 9 
of murine incisional and excisional acute wound models. Wound Repair Regen 10 
2014;22(2):281-7. 11 
Attinger C., Wolcott R. Clinically Addressing Biofilm in Chronic Wounds. Adv Wound Care  12 
2012;1(3):127-32. 13 
Beaumont P. E., McHugh B., Gwyer Findlay E., Mackellar A., Mackenzie K. J., Gallo R. L., 14 
et al. Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas 15 
aeruginosa infection by its influence on neutrophil function in vivo. PLoS One 16 
2014;9(6):e99029. 17 
Bowcutt R., Bramhall M., Logunova L., Wilson J., Booth C., Carding S. R., et al. A role for 18 
the pattern recognition receptor Nod2 in promoting recruitment of CD103+ dendritic cells to 19 
the colon in response to Trichuris muris infection. Mucosal Immunol 2014;7(5):1094-105. 20 
Buchau A. S., Hassan M., Kukova G., Lewerenz V., Kellermann S., Wurthner J. U., et al. 21 
S100A15, an antimicrobial protein of the skin: regulation by E. coli through Toll-like 22 
receptor 4. J Invest Dermatol 2007;127(11):2596-604. 23 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
19 
 
Campbell L., Williams H., Crompton R. A., Cruickshank S. M., Hardman M. J. Nod2 1 
deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing 2 
response. J Pathol 2013;229(1):121-31. 3 
Caporaso J. G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F. D., Costello E. K., et 4 
al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 5 
2010;7(5):335-6. 6 
Choi K. Y., Chow L. N., Mookherjee N. Cationic host defence peptides: multifaceted role in 7 
immune modulation and inflammation. J Innate Immun 2012;4(4):361-70. 8 
Cruickshank S. M., Wakenshaw L., Cardone J., Howdle P. D., Murray P. J., Carding S. R. 9 
Evidence for the involvement of NOD2 in regulating colonic epithelial cell growth and 10 
survival. World J Gastroenterol 2008;14(38):5834-41. 11 
Dasu M. R., Devaraj S., Park S., Jialal I. Increased toll-like receptor (TLR) activation and 12 
TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010;33(4):861-8. 13 
Dorschner R. A., Pestonjamasp V. K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., et al. 14 
Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against 15 
group A Streptococcus. J Invest Dermatol 2001;117(1):91-7. 16 
Dutta P., Das S. Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against 17 
Infection and Chronic Inflammation. Curr Top Med Chem 2016;16(1):99-129. 18 
Eming S. A., Martin P., Tomic-Canic M. Wound repair and regeneration: mechanisms, 19 
signaling, and translation. Sci Transl Med 2014;6(265):265sr6. 20 
Feerick C. L., McKernan D. P. Understanding the regulation of pattern recognition receptors 21 
in inflammatory diseases - a 'Nod' in the right direction. Immunology 2017;150(3):237-47. 22 
Gallo R. L., Hooper L. V. Epithelial antimicrobial defence of the skin and intestine. Nat Rev 23 
Immunol 2012;12(7):503-16. 24 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
20 
 
Gambichler T., Skrygan M., Appelhans C., Tomi N. S., Reinacher-Schick A., Altmeyer P., et 1 
al. Expression of human beta-defensins in patients with mycosis fungoides. Arch Dermatol 2 
Res 2007;299(4):221-4. 3 
Glaser R., Harder J., Lange H., Bartels J., Christophers E., Schroder J. M. Antimicrobial 4 
psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 5 
2005;6(1):57-64. 6 
Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary 7 
department structure and surgical treatment facilities in the treatment of chronic wounds. Am 8 
J Surg 2004;187(5A):38S-43S. 9 
Grice E. A., Segre J. A. The human microbiome: our second genome. Annu Rev Genomics 10 
Hum Genet 2012a;13:151-70. 11 
Grice E. A., Segre J. A. Interaction of the microbiome with the innate immune response in 12 
chronic wounds. Adv Exp Med Biol 2012b;946:55-68. 13 
Grice E. A., Snitkin E. S., Yockey L. J., Bermudez D. M., Program N. C. S., Liechty K. W., 14 
et al. Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense 15 
response. Proc Natl Acad Sci U S A 2010;107(33):14799-804. 16 
Hager B., Bickenbach J. R., Fleckman P. Long-term culture of murine epidermal 17 
keratinocytes. J Invest Dermatol 1999;112(6):971-6. 18 
Halverson T. W., Wilton M., Poon K. K., Petri B., Lewenza S. DNA is an antimicrobial 19 
component of neutrophil extracellular traps. PLoS Pathog 2015;11(1):e1004593. 20 
Harder J., Schroder J. M., Glaser R. The skin surface as antimicrobial barrier: present 21 
concepts and future outlooks. Exp Dermatol 2013;22(1):1-5. 22 
Hardman M. J., Ashcroft G. S. Estrogen, not intrinsic aging, is the major regulator of delayed 23 
human wound healing in the elderly. Genome Biol 2008;9(5):R80. 24 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
21 
 
Hinojosa C. A., Boyer-Duck E., Anaya-Ayala J. E., Nunez-Salgado A., Laparra-Escareno H., 1 
Torres-Machorro A., et al. Impact of the bacteriology of diabetic foot ulcers in limb loss. 2 
Wound Repair Regen 2016;24(5):923-7. 3 
Hinrichsen K., Podschun R., Schubert S., Schroder J. M., Harder J., Proksch E. Mouse beta-4 
defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents 5 
Chemother 2008;52(5):1876-9. 6 
James G. A., Swogger E., Wolcott R., Pulcini E., Secor P., Sestrich J., et al. Biofilms in 7 
chronic wounds. Wound Repair Regen 2008;16(1):37-44. 8 
Kobayashi K. S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. 9 
Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 10 
2005;307(5710):731-4. 11 
Kurokawa T., Kikuchi T., Ohta K., Imai H., Yoshimura N. Ocular manifestations in Blau 12 
syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003;110(10):2040-4. 13 
Lai Y., Di Nardo A., Nakatsuji T., Leichtle A., Yang Y., Cogen A. L., et al. Commensal 14 
bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 15 
2009;15(12):1377-82. 16 
Lesage S., Zouali H., Cezard J. P., Colombel J. F., Belaiche J., Almer S., et al. 17 
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with 18 
inflammatory bowel disease. Am J Hum Genet 2002;70(4):845-57. 19 
Lin Q., Wang L., Lin Y., Liu X., Ren X., Wen S., et al. Toll-like receptor 3 ligand 20 
polyinosinic:polycytidylic acid promotes wound healing in human and murine skin. J Invest 21 
Dermatol 2012;132(8):2085-92. 22 
Lipsky B. A., Peters E. J., Berendt A. R., Senneville E., Bakker K., Embil J. M., et al. 23 
Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res 24 
Rev 2012;28 Suppl 1:234-5. 25 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
22 
 
Loesche M., Gardner S. E., Kalan L., Horwinski J., Zheng Q., Hodkinson B. P., et al. 1 
Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing. J Invest 2 
Dermatol 2017;137(1):237-44. 3 
Mancl K. A., Kirsner R. S., Ajdic D. Wound biofilms: lessons learned from oral biofilms. 4 
Wound Repair Regen 2013;21(3):352-62. 5 
Mangoni M. L., McDermott A. M., Zasloff M. Antimicrobial peptides and wound healing: 6 
biological and therapeutic considerations. Exp Dermatol 2016;25(3):167-73. 7 
McGlasson S. L., Semple F., MacPherson H., Gray M., Davidson D. J., Dorin J. R. Human 8 
beta-defensin 3 increases the TLR9-dependent response to bacterial DNA. Eur J Immunol 9 
2017;47(4):658-64. 10 
Misic A. M., Gardner S. E., Grice E. A. The Wound Microbiome: Modern Approaches to 11 
Examining the Role of Microorganisms in Impaired Chronic Wound Healing. Adv Wound 12 
Care (New Rochelle) 2014;3(7):502-10. 13 
Mookherjee N., Hancock R. E. Cationic host defence peptides: innate immune regulatory 14 
peptides as a novel approach for treating infections. Cell Mol Life Sci 2007;64(7-8):922-33. 15 
Moore L. E., Ledder R. G., Gilbert P., McBain A. J. In vitro study of the effect of cationic 16 
biocides on bacterial population dynamics and susceptibility. Appl Environ Microbiol 17 
2008;74(15):4825-34. 18 
Navid F., Boniotto M., Walker C., Ahrens K., Proksch E., Sparwasser T., et al. Induction of 19 
regulatory T cells by a murine beta-defensin. J Immunol 2012;188(2):735-43. 20 
Okansen J. F., Blanchet G., Friendly M., Kindt R., Legendre P., McGlinn D., et al. vegan: 21 
Community Ecology Package, https://CRAN.R-project.org/package=vegan; 2016 [Accessed 22 
January 17 2017]. 23 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
23 
 
Ong P. Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous 1 
antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2 
2002;347(15):1151-60. 3 
Papanas N., Mani R. Advances in infections and wound healing for the diabetic foot: the die 4 
is cast. Int J Low Extrem Wounds 2013;12(2):83-6. 5 
Philpott D. J., Sorbara M. T., Robertson S. J., Croitoru K., Girardin S. E. NOD proteins: 6 
regulators of inflammation in health and disease. Nat Rev Immunol 2014;14(1):9-23. 7 
Price L. B., Liu C. M., Frankel Y. M., Melendez J. H., Aziz M., Buchhagen J., et al. 8 
Macroscale spatial variation in chronic wound microbiota: a cross-sectional study. Wound 9 
Repair Regen 2011;19(1):80-8. 10 
Reynolds N. L., De Cecco M., Taylor K., Stanton C., Kilanowski F., Kalapothakis J., et al. 11 
Peptide fragments of a beta-defensin derivative with potent bactericidal activity. Antimicrob 12 
Agents Chemother 2010;54(5):1922-9. 13 
Rhoads D. D., Cox S. B., Rees E. J., Sun Y., Wolcott R. D. Clinical identification of bacteria 14 
in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing. BMC 15 
Infect Dis 2012;12:321. 16 
Rohrl J., Yang D., Oppenheim J. J., Hehlgans T. Identification and Biological 17 
Characterization of Mouse beta-defensin 14, the orthologue of human beta-defensin 3. J Biol 18 
Chem 2008;283(9):5414-9. 19 
Schneider J. J., Unholzer A., Schaller M., Schafer-Korting M., Korting H. C. Human 20 
defensins. J Mol Med (Berl) 2005;83(8):587-95. 21 
Semple F., MacPherson H., Webb S., Kilanowski F., Lettice L., McGlasson S. L., et al. 22 
Human beta-Defensin 3 Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral 23 
Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid. PLoS Genet 24 
2015;11(12):e1005673. 25 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
24 
 
Simanski M., Dressel S., Glaser R., Harder J. RNase 7 protects healthy skin from 1 
Staphylococcus aureus colonization. J Invest Dermatol 2010;130(12):2836-8. 2 
Sorensen O. E., Thapa D. R., Roupe K. M., Valore E. V., Sjobring U., Roberts A. A., et al. 3 
Injury-induced innate immune response in human skin mediated by transactivation of the 4 
epidermal growth factor receptor. J Clin Invest 2006;116(7):1878-85. 5 
Tan G., Zeng B., Zhi F. C. Regulation of human enteric alpha-defensins by NOD2 in the 6 
Paneth cell lineage. Eur J Cell Biol 2015;94(1):60-6. 7 
Team R. C. 2016, https://www.R-project.org; 2016 [accessed 3rd January 2017]. 8 
Venables W. N., Ripley B. D. Modern Applied Statistics with S. 4th ed. New York: Springer, 9 
2002. 10 
Walter J., Tannock G. W., Tilsala-Timisjarvi A., Rodtong S., Loach D. M., Munro K., et al. 11 
Detection and identification of gastrointestinal Lactobacillus species by using denaturing 12 
gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 13 
2000;66(1):297-303. 14 
Wang B., McHugh B. J., Qureshi A., Campopiano D. J., Clarke D. J., Fitzgerald J. R., et al. 15 
IL-1beta-Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted 16 
Proteases Is Mediated by Human beta-Defensin 2. J Invest Dermatol 2017;137(1):95-105. 17 
Watanabe T., Kitani A., Murray P. J., Strober W. NOD2 is a negative regulator of Toll-like 18 
receptor 2-mediated T helper type 1 responses. Nat Immunol 2004;5(8):800-8. 19 
Williams H., Crompton R. A., Thomason H. A., Campbell L., Singh G., McBain A. J., et al. 20 
Cutaneous Nod2 Expression Regulates the Skin Microbiome and Wound Healing in a Murine 21 
Model. J Invest Dermatol 2017;137(11):2427-36. 22 
Wolcott R. D., Hanson J. D., Rees E. J., Koenig L. D., Phillips C. D., Wolcott R. A., et al. 23 
Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. 24 
Wound Repair Regen 2016;24(1):163-74. 25 
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
25 
 
Yang B., Suwanpradid J., Sanchez-Lagunes R., Choi H. W., Hoang P., Wang D., et al. IL-27 1 
Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host 2 
Defense. J Invest Dermatol 2017;137(5):1166-75. 3 
Zanger P. Staphylococcus aureus positive skin infections and international travel. Wien Klin 4 
Wochenschr 2010;122 Suppl 1:31-3. 5 
FIGURE LEGENDS 6 
Figure 1. The microbiome profile of human DFUs is an indicator of healing outcome. 7 
DFU samples were collected at baseline and their wound microbial communities sequenced 8 
by 16S PCR-DGGE or 16S RNA Illumina high-throughput sequencing. Longitudinal healing 9 
was measured over the subsequent 12 weeks to define healing outcome. (a) UPGMA 10 
dendrogram of DFU DGGE fingerprints for healed (green) and non-healed (purple) wound 11 
tissue revealed clustering based on time to heal, ≥60% intrapersonal variation versus ≤30% 12 
interpersonal variation. (b) NMDS plot showing differences in clustering of microbial 13 
communities from 16S RNA Illumina high-throughput sequencing and (c) diversity which 14 
was calculated using Shannon Weiner. (d-e) Taxonomic classification of the skin 15 
microbiome, showing proportion of bacteria, in each treatment group, at the phylum level and 16 
genus level. Individual taxa with abundances too low to visualise clearly and unassigned 17 
reads are grouped into the ‘other’ category, comprised of 12 additional phyla plus unassigned 18 
reads at the phylum level, and 225 additional genera plus unassigned reads at the genus level. 19 
(f) Representative Gram stained histological sections and (g) quantification of numbers of 20 
bacteria per field of view. All data are representative of two independent experiments, with n 21 
= 19 patients for (a) and n = 25 for (b-g). * P<0.05. P values were determined by one-way 22 
ANOVA  (b-c); two-way ANOVA (d-e) with Tukey post hoc test or by a paired, two-tailed 23 
Student’s t-test (g). Mean + s.e.m. Scale bar = 20 µm (f). 24 
 25 
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Figure 2. Altered PRR expression in non-healing human DFUs. DFU samples were 1 
collected at baseline, with longitudinal healing measured over the subsequent 12 weeks. RT-2 
qPCR profiling of (a-e) TLR members and (f) NOD2 in patient wound samples collected at 3 
first visit with the patients subsequently categorized into either the healed wound group or the 4 
non-healed wound group. (g) Representative crystal-violet stained human keratinocyte 5 
scratch wounds stimulated with 1 µg/ml MDP or control for 24 hours (dashed white line 6 
indicates initial scratch width; green line illustrates epidermal sheet edge measured) and (h) 7 
quantification of NHEK scratch closure in the presence or absence of mitomycin C.  (i) 8 
NOD2 mRNA analyzed by qPCR. All data are representative of two-three independent 9 
experiments, with n = 19 patients in total (a-f), and n = 7-8 per treatment (g-i). * P<0.05. P 10 
values were determined by a non-parametric permutational multivariate analysis of variance 11 
in a, or paired, two-tailed Student’s t-test (b-i). Mean + s.e.m. Scale bar = 300 µm (g). 12 
 13 
Figure 3. Stimulation of the Nod2 pathway significantly delays murine cutaneous wound 14 
healing. (a) Representative IHC (keratin 14) of control or MDP injected incisional wounds 15 
(day 3), arrows denote wound margins. (b) Analysis of histological wound area and (c) re-16 
epithelialization. (d) Representative IHC of neutrophil and macrophages in control or MDP 17 
injected wounds at 3 days post-wounding, and quantification of (e) neutrophils and (f) 18 
macrophages (illustrated method figure S3). (g) Analysis of the distance contribution from 19 
the wound edge of keratin 6 expressing epidermal keratinocytes at 3 days post-wounding and 20 
(h) representative, keratin 6-stained images of control and MDP injected wounds at 3 days 21 
post-wounding; arrows indicate the cessation of keratin 6 expression. (i) Quantification of the 22 
percent of basal keratinocytes expressing proliferation marker Ki67. Wound edge = 0-500µm 23 
from the wound and per-wound edge = 500-1000µm from the wound. (j) Representative Ki67 24 
staining, denoting location of wound and peri-wound edge. All data are representative of two-25 
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three independent experiments with n = 6 mice/group. *** P<0.001, ** P<0.01, * P<0.05. P 1 
values were determined by paired, two-tailed Student’s t-test. Mean + s.e.m. Scale bar = 200 2 
µm (a, d), 50 µm (h,j). 3 
 4 
Figure 4. Nod2 stimulation alters defensin profile. qPCR analysis of cutaneous mBD1, 3 5 
and 14 or hBD1, 2 and 3 in control versus 1ug/ml MDP treated (a) wounds or (b) NHEKs. (c) 6 
Primary mouse keratinocyte monolayers were scratched and treated with 1, 10 or 25 µg/ml of 7 
mBD14 peptide and their closure assessed after 96 hours (dashed white line indicates initial 8 
scratch width; green line illustrates epidermal sheet edge measured) (d). All data are 9 
representative of two-three independent experiments with n = 6 mice/group (a), and n = 7-8 10 
wells/dose (b-d). *** P<0.001, * P<0.05. P values were determined by paired, two-tailed 11 
Student’s t-test or one-way ANOVA for more than 2 groups. Mean + s.e.m.. 12 
 13 
Figure 5. Delayed healing in Defb14-deficient mice. Defb14-/- mice and littermate controls 14 
were excisionally wounded and analyzed three days post-wounding. (a) Representative 15 
hematoxylin and eosin stained sections of Defb14-/- excisional wounds (day 3), arrows 16 
indicate wound margins. Analysis of histological wound area (b), and re-epithelialization (c) 17 
at day 3 post-wounding. Analysis of the distance contribution from the wound edge (d) and 18 
neo-epidermal area (e) of keratin 6 expressing epidermal keratinocytes, illustrated in 19 
representative images of WT and Defb14-/- wounds at 3 days post-wounding (f); dashed 20 
outline indicates neo-epidermal area. (g) Quantification of the percent of basal keratinocytes 21 
expressing proliferation marker Ki67. Wound edge = 0-500µm from the wound and per-22 
wound edge = 500-1000µm from the wound. (j) Representative Ki67 staining, denoting 23 
location of wound and peri-wound edge. IHC quantification of (i) neutrophils and (j) 24 
macrophages. Further characterisation of macrophage polarisation looked at the proportion of 25 
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(k) iNOS+ or (l) Arg1+ macrophages (illustrated method figure S3). All data are 1 
representative of two independent experiments with n = 5-6 mice/group. ** P <0.01, * 2 
P<0.05. P values were determined by paired, two-tailed Student’s t-test. Mean + s.e.m. Scale 3 
bar = 200 µm (a); 100 µm (f); 50 µm (h, i-l).  4 
 5 
Figure 6. Bacterial dysbiosis in Defb14-deficient mice. (a) Gram-stain of representative 6 
histological sections and (b) quantification reveals altered bacterial burden in Defb14-/- day 3 7 
wounds compared to control. (c) This is confirmed through RT-qPCR (eubacterial 16S) of 8 
total bacterial abundance which demonstrates a significant increase compared to WT 9 
littermate controls. These differences are associated with a significant increase of (d) P. 10 
aeruginosa, and (e) P. acnes as revealed by RT species-specific qPCR. All data are 11 
representative of two independent experiments with n = 5-6 mice/group. ** P<0.01, * 12 
P<0.05. P values were determined by paired, two-tailed Student’s t-test. Mean + s.e.m. Scale 13 
bar = 20 µm (a).   14 
 15 
 16 
